RICHARD A PROCTOR, MD
Osteopathic Medicine at Highland Ave, Madison, WI
License number
Wisconsin 20338
Category
Osteopathic Medicine
Type
Infectious Disease
Address
Address
600 Highland Ave, Madison, WI 53792
Phone
(608) 263-0943
(608) 263-9103 (Fax)
(608) 829-5201
(608) 263-9103 (Fax)
(608) 829-5201
Organization information
See more information about RICHARD A PROCTOR at bizstanding.comRichard Proctor MD
600 Highland Ave, Madison, WI 53792
Industry:
Internist
Phone:
(608) 263-0943 (Phone)
Richard Allan Proctor
Professional information
Dr. Richard A Proctor, Madison WI - MD (Doctor of Medicine)
Specialties:
Infectious Disease Medicine
Address:
University of Wisconsin Hospital and Clinics
600 Highland Ave, Madison 53792
(608) 263-6400 (Phone), (608) 829-5315 (Fax)
600 Highland Ave, Madison 53792
(608) 263-6400 (Phone), (608) 829-5315 (Fax)
Certifications:
Infectious Disease, 1978, Internal Medicine, 1976
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
UNIVERSITY OF MICHIGAN / ANN ARBOR
University of Wisconsin Hospitals and Clinics
Medstar-Georgetown University Medical Center
UNIVERSITY OF MICHIGAN / ANN ARBOR
University of Wisconsin Hospitals and Clinics
Medstar-Georgetown University Medical Center
Non-Absorbent Articles Including Aromatic Compositions As Inhibitors Of Exoprotein Production
US Patent:
2007015, Jul 5, 2007
Filed:
Mar 21, 2007
Appl. No.:
11/689060
Inventors:
Rae Syverson - Fond du Lac WI, US
Richard Proctor - Madison WI, US
Richard Proctor - Madison WI, US
Assignee:
KIMBERLY-CLARK WORLDWIDE, INC. - Neenah WI
International Classification:
A61K 31/325, A61K 31/165, A61K 8/73
US Classification:
424070130, 514485000, 514617000
Abstract:
Non-absorbent articles are disclosed. The non-absorbent articles include an effective amount of an aromatic inhibitory compound to substantially inhibit the production of exotoxins by Gram positive bacteria. The aromatic inhibitory compounds of the present invention have the general formula:
wherein Ris selected from the group consisting of H,
and NHand salts thereof; Ris a monovalent saturated or unsaturated aliphatic hydrocarbyl moiety; Ris a divalent saturated or unsaturated aliphatic hydrocarbyl moiety; Ris a trivalent saturated or unsaturated aliphatic hydrocarbyl moiety; Ris a monovalent substituted or unsubstituted saturated or unsaturated aliphatic hydrocarbyl moiety which may or may not be interrupted with hetero atoms; R, R, and Rare independently selected from the group consisting of H, OH, COOH, and —C(O)R; Ris hydrogen or a monovalent saturated or unsaturated aliphatic hydrocarbyl moiety.
Aromatic Compositions As Inhibitors Of Exoprotein Production In Non-Absorbent Articles
US Patent:
2010027, Oct 28, 2010
Filed:
Mar 8, 2007
Appl. No.:
11/683879
Inventors:
Rae Ellen Syverson - Fond du Lac WI, US
Richard A. Proctor - Madison WI, US
Richard A. Proctor - Madison WI, US
Assignee:
Kimberly-Clark Worldwide, Inc. - Neenah WI
International Classification:
A61M 31/00, A61F 6/06, A61F 2/02, A61F 13/26
US Classification:
600 30, 128830, 604 11, 604279
Abstract:
Non-absorbent articles are disclosed. The non-absorbent articles include an effective amount of an aromatic inhibitory compound to substantially inhibit the production of exotoxins by Gram positive bacteria. The aromatic inhibitory compounds of the present invention have the general formula:wherein Ris selected from the group consisting of H,and NHand salts thereof; Ris a monovalent saturated or unsaturated aliphatic hydrocarbyl moiety; Ris a divalent saturated or unsaturated aliphatic hydrocarbyl moiety; Ris a trivalent saturated or unsaturated aliphatic hydrocarbyl moiety; Ris a monovalent substituted or unsubstituted saturated or unsaturated aliphatic hydrocarbyl moiety which may or may not be interrupted with hetero atoms; R, R, and Rare independently selected from the group consisting of H, OH, COOH, and —C(O)R; Ris hydrogen or a monovalent saturated or unsaturated aliphatic hydrocarbyl moiety.
Aromatic Compositions For The Inhibition Of Exoprotein Production From Gram Positive Bacteria
US Patent:
2006013, Jun 22, 2006
Filed:
Dec 28, 2005
Appl. No.:
11/320184
Inventors:
Rae Syverson - Fond du Lac WI, US
Richard Proctor - Madison WI, US
Richard Proctor - Madison WI, US
Assignee:
Kimberly-Clark Worldwide, Inc. - Neenah WI
International Classification:
A61K 31/192, A61K 31/165
US Classification:
514568000, 514617000
Abstract:
Compositions including an aromatic compound for inhibiting the production of exoproteins by Gram positive bacteria are disclosed. The aromatic inhibitory compounds of the present invention have the general formula:
wherein Ris selected from the group consisting of H,
and salts thereof; Ris a monovalent saturated or unsaturated aliphatic hydrocarbyl moiety; Ris a divalent saturated or unsaturated aliphatic hydrocarbyl moiety; Ris a trivalent saturated or unsaturated aliphatic hydrocarbyl moiety; Ris a monovalent substituted or unsubstituted saturated or unsaturated aliphatic hydrocarbyl moiety which may or may not be interrupted with hetero atoms; R, R, and Rare independently selected from the group consisting of H, OH, COOH, and —C(O)R; Ris hydrogen or a monovalent saturated or unsaturated aliphatic hydrocarbyl moiety.
Staphylococcal Fibronectin Receptor, Monoclonal Antibodies Thereto And Methods Of Use
US Patent:
5034515, Jul 23, 1991
Filed:
Sep 22, 1987
Appl. No.:
7/099756
Inventors:
Richard A. Proctor - Madison WI
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
C07H 100, C07H 1522, C07H 1702, C07H 106
US Classification:
536 11
Abstract:
A purified fibronectin receptor polysaccharide derived from Staphylococcus aureus is useful as an antigen for diagnostic tests and the preparation of monoclonal antibodies. The fibronectin receptor polysaccharide is prepared by gently removing expresed material, including the polysaccharide, from the cell surfaces of the S. aureus without killing the cells followed by purification. Monoclonal antibodies directed against the polysaccharide can be used in methods of preventing or treating S. aureus infections by administering the monoclonal antibodies to animals.
Inhibition Of Exoprotein Production Using Isoprenoid Compositions
US Patent:
7294651, Nov 13, 2007
Filed:
Jul 27, 2004
Appl. No.:
10/900251
Inventors:
Rae Ellen Syverson - Fond du Lac WI, US
Richard A. Proctor - Madison WI, US
Richard A. Proctor - Madison WI, US
Assignee:
Kimberly-Clark Worldwide, Inc. - Neenah WI
International Classification:
A61K 31/05, A61K 9/00
US Classification:
514550, 514724, 514729, 514731, 514739, 514762, 514763, 514967
Abstract:
Methods and compositions for inhibiting the production of exotoxins are disclosed. The compositions include an effective amount of an isoprenoid inhibitory compound to substantially inhibit the production of exotoxins by Gram positive bacteria.
Aromatic Compositions As Inhibitors Of Exoprotein Production In Non-Absorbent Articles
US Patent:
7258867, Aug 21, 2007
Filed:
Mar 18, 2004
Appl. No.:
10/803345
Inventors:
Rae Ellen Syverson - Fond du Lac WI, US
Richard A. Proctor - Madison WI, US
Richard A. Proctor - Madison WI, US
Assignee:
Kimberly-Clark Worldwide, Inc. - Neenah WI
International Classification:
A61F 9/00, A61F 13/15, A01N 25/34
US Classification:
424400, 424402, 424404, 604360
Abstract:
Non-absorbent articles are disclosed. The non-absorbent articles include an effective amount of an aromatic inhibitory compound to substantially inhibit the production of exotoxins by Gram positive bacteria. The aromatic inhibitory compounds of the present invention have the general formula:.
Non-Absorbent Articles Containing Additives
US Patent:
2009003, Feb 5, 2009
Filed:
Oct 16, 2008
Appl. No.:
12/252842
Inventors:
Rae Ellen Syverson - Fond du Lac WI, US
Richard A. Proctor - Madison WI, US
Richard A. Proctor - Madison WI, US
Assignee:
KIMBERLY-CLARK WORLDWIDE, INC. - Neenah WI
International Classification:
A61K 9/70, A61K 31/407
US Classification:
424431, 514421
Abstract:
Non-absorbent articles containing an additive are disclosed. The non-absorbent articles include an effective amount of an inhibitory compound such as cerulenin, triclosan, or hexachloroprene, for example, to substantially inhibit the production of TSST-1 by Gram positive bacteria.
Absorbent Articles Containing Additives
US Patent:
7118759, Oct 10, 2006
Filed:
Oct 16, 2002
Appl. No.:
10/271513
Inventors:
Rae Ellen Syverson - Fond du Lac WI, US
Richard A. Proctor - Madison WI, US
Richard A. Proctor - Madison WI, US
Assignee:
Kimberly-Clark Worldwide, Inc. - Neenah WI
International Classification:
A01N 25/34, A61F 6/06, A61F 13/02
US Classification:
424404, 424411, 424430, 424431
Abstract:
Effective amounts of the inhibitory compounds described herein capable of significantly reducing the production of TSST-1 are as follows: (1) compounds of Structure (I): from about 0. 0001 micromoles/gram absorbent product to about 0. 08 micromoles/gram absorbent product, desirably from about 0. 0005 micromoles/gram of absorbent product to about 0. 05 micromoles/gram of absorbent product; and (2) compounds of Structures (II) and (III): from about 0. 05 micromoles/gram of absorbent product to 5 micromoles/gram of absorbent product, desirably from about 0. 1 micromoles/gram of absorbent product to about 1 micromole/gram of absorbent product. Specifically, effective amounts of hexachlorophene include from about 0. 00024 micromoles/gram of absorbent product to about 0. 08 micromoles/gram of absorbent product, desirably from about 0.
Method Reducing Tnf-Alpha In Mammals With Cerebral Malaria
US Patent:
5624913, Apr 29, 1997
Filed:
Aug 30, 1994
Appl. No.:
8/298254
Inventors:
Richard A. Proctor - Madison WI
Paul J. Bertics - Fitchburg WI
Paul J. Bertics - Fitchburg WI
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
A61K 3170, C07H 19167, C07H 1920
US Classification:
514 47
Abstract:
A method for reducing the TNF-alpha in mammals with cerebral malaria comprising the administration of 2-methylthio-ATP or 2-chloro-ATP.